Ignite Creation Date:
2025-12-24 @ 5:39 PM
Ignite Modification Date:
2026-02-23 @ 8:57 PM
Study NCT ID:
NCT02512068
Status:
COMPLETED
Last Update Posted:
2023-12-12
First Post:
2015-07-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Disease
Sponsor:
Takeda
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-08-07
Start Date Type:
ACTUAL
Primary Completion Date:
2018-04-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-04-24
Completion Date Type:
ACTUAL
First Submit Date:
2015-07-28
First Submit QC Date:
None
Study First Post Date:
2015-07-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-04-22
Results First Submit QC Date:
None
Results First Post Date:
2019-11-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-07
Last Update Post Date:
2023-12-12
Last Update Post Date Type:
ACTUAL